Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mouth Neoplasms | 7 | 2017 | 206 | 2.190 |
Why?
|
| RNA, Small Interfering | 6 | 2019 | 434 | 2.020 |
Why?
|
| Autoantigens | 7 | 2015 | 91 | 1.410 |
Why?
|
| Peptides | 3 | 2022 | 455 | 1.180 |
Why?
|
| MicroRNAs | 7 | 2022 | 447 | 1.120 |
Why?
|
| Ribonuclease III | 4 | 2014 | 16 | 0.980 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2014 | 20 | 0.840 |
Why?
|
| Nucleic Acids | 1 | 2022 | 16 | 0.830 |
Why?
|
| Membrane Proteins | 3 | 2015 | 617 | 0.780 |
Why?
|
| Cytoplasmic Structures | 5 | 2007 | 8 | 0.760 |
Why?
|
| Neoplasms | 2 | 2022 | 1667 | 0.680 |
Why?
|
| RNA Interference | 5 | 2013 | 266 | 0.680 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2014 | 629 | 0.640 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 173 | 0.640 |
Why?
|
| Arginine | 2 | 2015 | 102 | 0.560 |
Why?
|
| Gene Silencing | 4 | 2015 | 137 | 0.530 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2015 | 8 | 0.520 |
Why?
|
| Oncogenes | 1 | 2013 | 71 | 0.430 |
Why?
|
| Cell Line, Tumor | 6 | 2015 | 1851 | 0.340 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2007 | 43 | 0.290 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 1083 | 0.270 |
Why?
|
| RNA, Messenger | 6 | 2015 | 1664 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 756 | 0.250 |
Why?
|
| Autoimmunity | 1 | 2006 | 118 | 0.250 |
Why?
|
| Animals | 10 | 2019 | 20881 | 0.220 |
Why?
|
| Humans | 18 | 2022 | 68618 | 0.200 |
Why?
|
| Polymers | 1 | 2022 | 244 | 0.180 |
Why?
|
| Endosomes | 1 | 2019 | 45 | 0.170 |
Why?
|
| Mice | 7 | 2017 | 8474 | 0.160 |
Why?
|
| ErbB Receptors | 2 | 2017 | 239 | 0.150 |
Why?
|
| RNA-Binding Proteins | 5 | 2006 | 215 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 89 | 0.150 |
Why?
|
| Heterografts | 1 | 2017 | 70 | 0.150 |
Why?
|
| HeLa Cells | 5 | 2012 | 237 | 0.140 |
Why?
|
| Eukaryotic Initiation Factor-2 | 2 | 2006 | 17 | 0.130 |
Why?
|
| Peptide Initiation Factors | 2 | 2006 | 11 | 0.130 |
Why?
|
| Argonaute Proteins | 2 | 2006 | 13 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2017 | 291 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2015 | 132 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 216 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2015 | 294 | 0.120 |
Why?
|
| Cytoplasm | 2 | 2006 | 155 | 0.120 |
Why?
|
| Alternative Splicing | 1 | 2014 | 93 | 0.120 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 160 | 0.110 |
Why?
|
| Mice, Inbred NOD | 2 | 2012 | 138 | 0.110 |
Why?
|
| Cisplatin | 1 | 2014 | 192 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2012 | 238 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 135 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2014 | 305 | 0.110 |
Why?
|
| Transfection | 3 | 2010 | 782 | 0.110 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 27 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 76 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 194 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 40 | 0.090 |
Why?
|
| Saliva | 1 | 2011 | 142 | 0.090 |
Why?
|
| Mouth Diseases | 1 | 2010 | 39 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2010 | 149 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 320 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 196 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 261 | 0.080 |
Why?
|
| Lamin Type A | 2 | 2006 | 9 | 0.080 |
Why?
|
| Dependovirus | 1 | 2008 | 34 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1040 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 114 | 0.070 |
Why?
|
| RNA Transport | 1 | 2006 | 2 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 383 | 0.070 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2006 | 11 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 95 | 0.070 |
Why?
|
| Rheumatic Diseases | 1 | 2006 | 35 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 132 | 0.060 |
Why?
|
| Biomarkers | 1 | 2011 | 1593 | 0.060 |
Why?
|
| Cell Line | 2 | 2008 | 1752 | 0.060 |
Why?
|
| G2 Phase | 1 | 2004 | 26 | 0.060 |
Why?
|
| G1 Phase | 1 | 2004 | 42 | 0.060 |
Why?
|
| S Phase | 1 | 2004 | 38 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 532 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2006 | 312 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2008 | 442 | 0.060 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2003 | 11 | 0.060 |
Why?
|
| Calcium | 1 | 2008 | 929 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 742 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2003 | 52 | 0.060 |
Why?
|
| RNA | 1 | 2004 | 171 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2006 | 434 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2004 | 202 | 0.050 |
Why?
|
| Proteins | 1 | 2006 | 474 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 852 | 0.050 |
Why?
|
| RNA Stability | 3 | 2006 | 55 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2004 | 1174 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1174 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 122 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2012 | 326 | 0.020 |
Why?
|
| Transcriptome | 1 | 2012 | 164 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 282 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 521 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.020 |
Why?
|
| Cell Separation | 1 | 2008 | 132 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 312 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 258 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 508 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2673 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 22 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2004 | 22 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2004 | 35 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 41 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 27 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2004 | 124 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 10 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 127 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 65 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 102 | 0.010 |
Why?
|
| Acetylation | 1 | 2004 | 94 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2004 | 99 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 447 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 214 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 237 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 280 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 271 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 981 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1293 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2003 | 163 | 0.010 |
Why?
|
| Male | 2 | 2012 | 37321 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 5300 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2003 | 334 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 14862 | 0.010 |
Why?
|
| Female | 2 | 2011 | 38074 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 21403 | 0.010 |
Why?
|